Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Cameron J. Turtle, Erik L. Kimble et al.|Blood|2020Cited by 217
Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow CytometryDelaney R. Kirchmeier, Cameron J. Turtle, Alyssa Sheih et al.|Blood|2021Cited by 1
IL-15 Serum Concentrations and CD19 CAR T-Cell Therapy: Impact on Clinical Outcomes and In Vivo CAR T Cell KineticsJordan Gauthier, Cameron J. Turtle, Cassie Chou et al.|Transplantation and Cellular Therapy|2021Cited by 0